Navigation Links
UofL researcher receives grant from the National Science Foundation
Date:9/20/2010

Louisville, Ky. -- Michal Hetman, MD, PhD, associate professor and endowed chair in molecular signaling in the Kentucky Spinal Cord Injury Research Center and the UofL Department of Neurological Surgery, has received a three-year, $500,000 grant from the National Science Foundation to fund a project that will aim to explain how the nervous system grows and develops. This knowledge may someday help scientists develop better treatment strategies for illnesses and injuries that cause damage to the nervous system.

In the developing brain, growth of the extensions of nerve cells called dendrites is critical to establishing the connections between neurons that underlie brain function.

"This project aims to identify the critical elements of the signaling network underlying dendritic growth," Hetman said.

The study, using animal models, will specifically look at genes found in a subsection of the cell nucleus called the nucleolus and their contribution to dendritic growth.

This project will provide an opportunity for students from UofL and from Northern Kentucky University to contribute to the research as part of a 10-week summer program.


'/>"/>

Contact: Lauren Williams
lauren.williams@louisville.edu
502-852-7461
University of Louisville
Source:Eurekalert

Page: 1

Related biology news :

1. Marshall University researchers awarded more than $1 million for breast cancer studies
2. Case Western Reserve researcher discovers new anti-pathogenic drugs to treat MRSA
3. Neutrons helping ORNL researchers unlock secrets to cheaper ethanol
4. Researchers build artificial ovary to develop oocytes into mature human eggs
5. Researchers nationwide ask for new focus on sudden death heart disorder
6. WSU researchers discover key mechanism behind sleep
7. MIT researchers develop a way to funnel solar energy
8. Mount Sinai researchers analyze impact of chemical BPA in dental sealants used in children
9. Swine researchers seek answers to fibers low digestibility
10. Twins are intriguing research subjects for Notre Dame biometircs researchers
11. Researchers at UC Riverside find solution to cell death problem vexing stem cell research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016 /PRNewswire/ ... que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que ... de tumor en 2017, con múltiples sitios previstos a lo largo ... ... en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 AquaBounty Technologies, ... on enhancing productivity in aquaculture and a majority-owned subsidiary ... that it has completed the listing of its common ... equity subscription from Intrexon. "AquaBounty,s listing on ... will broaden our exposure to the U.S. markets as ...
(Date:1/19/2017)... Yorba Linda, Ca (PRWEB) , ... January 18, ... ... interactive virtual events for tech innovators, engineers, and scientists from around the world, ... Corporate American News. The awards program is based entirely on merit and decided ...
(Date:1/19/2017)... ... 19, 2017 , ... DaVita Clinical Research (DCR), ... and device development, and Prism Clinical Research , a leader in providing ... Verified Clinical Trials (VCT) has been selected by both companies as an ...
(Date:1/19/2017)... Md. , Jan. 18, 2017  Northwest Biotherapeutics, ... developing DCVax® personalized immune therapies for operable and inoperable ... Bosch , Chief Technical Officer of NW Bio, will ... January 19, 2017, at the Hyatt Regency Hotel in ... Bosch will chair the session entitled "New Therapeutic Approaches ...
Breaking Biology Technology: